Type 1 Diabetes REst for Metabolic Health
Recruiting now · Not applicable
Conditions studied: Type 1 Diabetes (T1D), Sleep Health
In brief
Research has shown a link between poor sleep health and late circadian timing with cardiometabolic health in adolescents with type 1 diabetes (T1D). Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in T1D, which begins as early as adolescence, and current therapies are limited. Therefore, this study plans to investigate whether cardiometabolic health can be improved with increased sleep duration and advanced circadian timing in adolescents with T1D with habitually insufficient sleep. To answer this question, investigators will study adolescents with T1D who get \<7h sleep on school nights and measure changes in insulin sensitivity, glycemic control, and vascular function after one month of a sleep and circadian intervention (1+ hour longer time in bed each night plus evening melatonin and morning light therapy) compared to one month of typical sleep (usual school schedule).
Key facts
- Study ID
- NCT06627504
- Run by
- University of Colorado, Denver
- People needed
- 50
- Starts
- 2025-08-12
- Expected to finish
- 2029-08-31
- Last updated by the study team
- 2026-06-03
Who can join
Age: 14 and older, up to 19. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- High school students between the ages of 14-19 years;
- Diagnosed with T1D for ≥1 year;
- Using an insulin pump or other automated insulin delivery system;
- Have typically insufficient sleep, defined by ≤ 7 h per night on school days (assessed by actigraphy);
- With or at risk for obesity based on either above-average weight (BMI ≥50th percentile) or parental history of obesity (BMI ≥ 30 kg/m2);
- Tanner stage 4 or 5, based on breast development for girls and testicular size for boys.
You may not qualify if…
- Prior diagnosis of a sleep disorder (e.g., insomnia, obstructive sleep apnea) or an elevated screening score on the OSA subscale of the Sleep Disorders Inventory for Students-Adolescents measure
- Regular use of medications affecting sleep (e.g., stimulants, atypical antipsychotics, melatonin or other sleep aids);
- Regular use of medications affecting IR (systemic steroids, adjunctive diabetes medications);
- HbA1c ≥12%;
- Severe illness or DKA within 60 days;
- IQ<70 or severe mental illness impacting sleep or ability to participate in the study;
- Night-shift employment or other obligations that would preclude adherence to the intervention.
Where it is running
- Children's Hospital Colorado — Aurora, Colorado, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.